Stay updated on Galunisertib with Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-02-19T15:48:11.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1.0%
    Check dated 2025-02-12T09:15:51.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-05T05:59:10.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    A new section has been added featuring helpful links from Eli Lilly and Company, including information about a study on Galunisertib in combination with Nivolumab for advanced solid tumors and specific cancers.
    Difference
    1%
    Check dated 2025-01-28T22:38:58.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-21T20:43:38.000Z thumbnail image
  9. Check
    63 days ago
    Change Detected
    Summary
    The website has been updated to include a new type of intervention in version 2.14.0, while the previous version 2.13.3 has removed the type of intervention and a detailed description of a study related to Galunisertib.
    Difference
    1%
    Check dated 2025-01-14T19:14:01.000Z thumbnail image

Stay in the know with updates to Galunisertib with Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.